相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjuvant multipeptide vaccination in high-risk early melanoma patients
P. Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Novel Multi-Peptide Vaccination In Hla-A2+Hormone Sensitive Patients With Biochemical Relapse of Prostate Cancer
Susan Feyerabend et al.
PROSTATE (2009)
Epitope landscape in breast and colorectal cancer
Neil H. Segal et al.
CANCER RESEARCH (2008)
Induction of tumor-specific CD4+ and CD8+ T-Cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2008)
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows lowtoxicity and robust immunogenicity
Gemma G. Kenter et al.
CLINICAL CANCER RESEARCH (2008)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Multiple roles for CD4(+) T cells in anti-tumor immune responses
Richard Kennedy et al.
IMMUNOLOGICAL REVIEWS (2008)
Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens
Craig L. Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer
Minal Barve et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer
Kimberly A. Chianese-Bullock et al.
JOURNAL OF IMMUNOTHERAPY (2008)
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy
Evelien L. J. M. Smits et al.
ONCOLOGIST (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
Taming cancer by inducing immunity via dendritic cells
A. Karolina Palucka et al.
IMMUNOLOGICAL REVIEWS (2007)
Immunologic and clinical outcomes of a Randomized phase II trial of two multipeptide Vaccines for melanoma in the adjuvant setting
Craig L. Slingluff et al.
CLINICAL CANCER RESEARCH (2007)
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Mario P. Colombo et al.
NATURE REVIEWS CANCER (2007)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma - Evidence of systemic immune dysfunction
Esteban Celis
CANCER (2007)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
Unique human tumor antigens: Immunobiology and use in clinical trials
Giorgio Parmiani et al.
JOURNAL OF IMMUNOLOGY (2007)
Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: Correlation with time to relapse in patients with resected high-risk disease
Omid Hamid et al.
CLINICAL CANCER RESEARCH (2007)
Vaccination therapy in prostate cancer
Andrea Marrari et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
Paal F. Brunsvig et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients
L Pilla et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Vaccination: role in metastatic melanoma
Lorenzo Pilla et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site
Victor Appay et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumor stroma-associated antigens for anti-cancer immunotherapy
V Hofmeister et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma:: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf et al.
ANNALS OF ONCOLOGY (2006)
Altered CD8+ T-cell responses when immunizing with multiepitope peptide vaccines
SA Rosenberg et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Inducing and expanding regulatory T cell populations by foreign antigen
K Kretschmer et al.
NATURE IMMUNOLOGY (2005)
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
V Lennerz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
CD4 T cells in tumor immunity
M Gerloni et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?
L Rivoltini et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients
Y Sato et al.
BRITISH JOURNAL OF CANCER (2004)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule
CL Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Competition among peptides in melanoma vaccines for binding to MHC molecules
LW Thompson et al.
JOURNAL OF IMMUNOTHERAPY (2004)
The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis
CG Colpaert et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Identification of a mutated receptor-like protein tyrosine phosphatase κ as a novel, class IIHLA-restricted melanoma antigen
L Novellino et al.
JOURNAL OF IMMUNOLOGY (2003)
Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides
C Scheibenbogen et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells
CL Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes:: Clinical and immunologic findings
F Belli et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides
S Zwaveling et al.
JOURNAL OF IMMUNOLOGY (2002)
Cancer immunotherapy with peptide-based vaccines: What have we achieved? - Where are we going?
G Parmiani et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma
P Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant:: Clinical and immunological responses in patients with pancreatic adenocarcinoma
MK Gjertsen et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Expression of hypoxia-lnducible cell-surface transmembrane carbonic anhydrases in human cancer
S Ivanov et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
